{
    "2018-09-09": [
        [
            {
                "time": "",
                "original_text": "乐视网拖累？还原创业板中报业绩增速较低“真相”",
                "features": {
                    "keywords": [
                        "乐视网",
                        "创业板",
                        "中报",
                        "业绩增速",
                        "较低"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "科技",
                        "传媒"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "730家创业板企业中报扫描：信息技术、新材料、生物产业奋起",
                "features": {
                    "keywords": [
                        "创业板",
                        "中报",
                        "信息技术",
                        "新材料",
                        "生物产业"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "信息技术",
                        "新材料",
                        "生物科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "医疗保健：自下而上选择穿越熊市 荐5股",
                "features": {
                    "keywords": [
                        "医疗保健",
                        "熊市",
                        "推荐股票"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医疗保健"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "股转回应摘牌潮、做市商退出、基金退出难题等问题；滨会生物定增被上市公司子公司全额认购",
                "features": {
                    "keywords": [
                        "股转系统",
                        "摘牌潮",
                        "做市商退出",
                        "基金退出",
                        "滨会生物",
                        "定增",
                        "全额认购"
                    ],
                    "sentiment_score": -0.4,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            }
        ]
    ]
}